Current IDA Treatment Issues: VITime® Contributes to Attending Physician Publication

10 November 2025

Iron-deficiency anemia (IDA) remains one of the most common conditions requiring close attention from doctors, especially in the context of reproductive health. This scientific article explores in great detail and with focused attention the risks of pregnancy and childbirth IDA- associated complications and also discusses some nutritional support strategies.

It is supplemented by the integration of the VITime® Classic Iron Chelate product module. So,reading the article, medical specialists can immediately learn about one of the IDA control options. The product contains iron in a chelated form (bisglycinate), which is characterized by high bioavailability and a safety profile. It also minimizes the risk of gastrointestinal side effects, which is really vital during pregnancy.

Being featured in a peer-reviewed media highlights the VITime® expert approach to product development and builds trust within the medical community.

Read the full text in the e-version of the journal: https://www.lvrach.ru/2025/10/15439651.